Risultati della ricerca - Chunxiao Xu
- Mostra 1 - 20 risultati su 34
- Vai alla pagina seguente
-
1
Diabetes and cancer: Associations, mechanisms, and implications for medical practice di Chunxiao Xu
Pubblicazione 2014Revisão -
2
-
3
-
4
The Association Between the Triglyceride–Glucose Index, Its Combination with the Body Roundness Index, and Chronic Kidney Disease in Patients with Type 2 Diabetes in Eastern China:... di Xiangyu Chen, Xiaofu Du, Feng Lü, Jie Zhang, Chunxiao Xu, Mingbin Liang, Lijin Chen, Jieming Zhong
Pubblicazione 2025Artigo -
5
-
6
-
7
-
8
Acquired Resistance to Dasatinib in Lung Cancer Cell Lines Conferred by<i>DDR2</i>Gatekeeper Mutation and<i>NF1</i>Loss di Ellen M. Beauchamp, Brittany A. Woods, Austin Dulak, Li Tan, Chunxiao Xu, Nathanael S. Gray, Adam J. Bass, Kwok‐Kin Wong, Matthew Meyerson, Peter S. Hammerman
Pubblicazione 2013Artigo -
9
-
10
Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in <i>EGFR</i>-Mutant Lung Cancer di Erin M. Tricker, Chunxiao Xu, Sharmeen Uddin, Marzia Capelletti, Dalia Ercan, Atsuko Ogino, Christine A. Pratilas, Neal Rosen, Nathanael S. Gray, Kwok‐Kin Wong, Pasi A. Jänne
Pubblicazione 2015Artigo -
11
miR-122, a Mammalian Liver-Specific microRNA, is Processed from hcr mRNA and MayDownregulate the High Affinity Cationic Amino Acid Transporter CAT-1 di Jinhong Chang, Émmanuelle Nicolas, Debora S. Marks, Chris Sander, Anthony Lerro, Marie Annick Buendia, Chunxiao Xu, William S. Mason, Thomas D. Moloshok, Roque Bort, Kenneth S. Zaret, John M. Taylor
Pubblicazione 2004Artigo -
12
-
13
Identification of Five Interferon-Induced Cellular Proteins That Inhibit West Nile Virus and Dengue Virus Infections di Dong Jiang, Jessica M. Weidner, Min Qing, Xiao‐Ben Pan, Haitao Guo, Chunxiao Xu, Xianchao Zhang, Alex Birk, Jinhong Chang, Pei‐Yong Shi, Timothy M. Block, Ju‐Tao Guo
Pubblicazione 2010Artigo -
14
Combined EGFR/MET or EGFR/HSP90 Inhibition Is Effective in the Treatment of Lung Cancers Codriven by Mutant EGFR Containing T790M and MET di Lu Xu, Eiki Kikuchi, Chunxiao Xu, Hiromichi Ebi, Dalia Ercan, Katherine A. Cheng, Robert F. Padera, Jeffrey A. Engelman, Pasi A. Jänne, Geoffrey I. Shapiro, Takeshi Shimamura, Kwok‐Kin Wong
Pubblicazione 2012Artigo -
15
Detection of Clonally Expanded Hepatocytes in Chimpanzees with Chronic Hepatitis B Virus Infection di William S. Mason, Huey-Chi Low, Chunxiao Xu, Carol E. Aldrich, Catherine A. Scougall, Arend Große, Andrew D. Clouston, Deborah Chavez, Samuel Litwin, Suraj Peri, Allison R. Jilbert, Robert E. Lanford
Pubblicazione 2009Artigo -
16
Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer Models di Chunxiao Xu, Yanping Zhang, Alex Rolfe, Vivian M. Hernández, Wilson Guzman, Giorgio Kradjian, Bo Marelli, Guozhong Qin, Jin Qi, Hong Wang, Huakui Yu, Robert M. Tighe, Kin-Ming Lo, Jessie M. English, Laszlo Radvanyi, Yan Lan
Pubblicazione 2017Artigo -
17
Intratumoral Heterogeneity in <i>EGFR</i>-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition di Margaret Soucheray, Marzia Capelletti, Inés Pulido, Yanan Kuang, Cloud P. Paweletz, Jeffrey H. Becker, Eiki Kikuchi, Chunxiao Xu, Tarun B. Patel, Fátima Al‐Shahrour, Julián Carretero, Kwok‐Kin Wong, Pasi A. Jänne, Geoffrey I. Shapiro, Takeshi Shimamura
Pubblicazione 2015Artigo -
18
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β di Yan Lan, Dong Zhang, Chunxiao Xu, Kenneth W. Hance, Bo Marelli, Jin Qi, Huakui Yu, Guozhong Qin, Aroop Sircar, Vivian M. Hernández, Molly H. Jenkins, Rachel E. Fontana, Amit Deshpande, George Locke, Helen Sabzevari, Laszlo Radvanyi, Kin-Ming Lo
Pubblicazione 2018Artigo -
19
Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers di Francesca Cottini, Teru Hideshima, Chunxiao Xu, Martin Sattler, Martina Dori, Luca Agnelli, Elisa ten Hacken, Maria Teresa Sabrina Bertilaccio, Elena Antonini, Antonino Neri, Maurilio Ponzoni, Magda Marcatti, Paul G. Richardson, Ruben D. Carrasco, Alec C. Kimmelman, Kwok‐Kin Wong, Federico Caligaris‐Cappio, Giovanni Blandino, W. Michael Kuehl, Kenneth C. Anderson, Giovanni Tonon
Pubblicazione 2014Artigo -
20
Inhibition of ALK, PI3K/MEK, and HSP90 in Murine Lung Adenocarcinoma Induced by <i>EML4-ALK</i> Fusion Oncogene di Zhao Chen, Takaaki Sasaki, Xiaohong Tan, Julián Carretero, Takeshi Shimamura, Danan Li, Chunxiao Xu, Yuchuan Wang, Guillaume Adelmant, Marzia Capelletti, Hyun Joo Lee, Scott J. Rodig, Christa L. Borgman, Seung-Il Park, Hyeong Ryul Kim, Robert F. Padera, Jarrod A. Marto, Nathanael S. Gray, Andrew L. Kung, Geoffrey I. Shapiro, Pasi A. Jänne, Kwok‐Kin Wong
Pubblicazione 2010Artigo
Strumenti per la ricerca:
Soggetti correlati
Biology
Gene
Genetics
Medicine
Cancer research
Internal medicine
Cancer
Cell biology
Kinase
Biochemistry
Lung cancer
Epidermal growth factor receptor
Virology
Virus
Gefitinib
Mutant
Oncology
Receptor
EGFR inhibitors
Endocrinology
Erlotinib
Immune system
Immunology
Mutation
RNA
Signal transduction
T790M
Tyrosine kinase
Chemistry
Diabetes mellitus